Report Categories
View AllRecent Articles
View All
The opportunity most miss about Kymera Therapeutics KYMR Slight Dip 20260508
How Ellington EFCB cash generation compares to earnings EFCB QX Earnings Ellington Declares 625 Preferred Dividend
MLACR Mountain quarterly filing shows no revenue as acquisition pipeline remains central focus for SPAC investors
RCON Recon posts narrower than expected Q4 2025 loss but shares dip 075 percent in trading today